SAN FRANCISCO , April 22, 2022 /PRNewswire/ — Nektar Therapeutics (NASDAQ:NKTR) will host an analyst and investor conference call with Nektar executives on Monday, April 25, 2022 , at 2:00 p.m. Pacific Standard Time (PST), to outline a new strategic plan for the company and provide updates for the

Original Source


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219